Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy
Abstract Bioreactors are essential tools for the development of efficient and high-quality cell therapy products. However, their application is far from full potential, holding several challenges when reconciling the complex biology of the cells to be expanded with the need for a manufacturing proce...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Journal of Biological Engineering |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13036-021-00264-7 |
id |
doaj-08f4f138bc094a688e4cf85ab8ba3e0c |
---|---|
record_format |
Article |
spelling |
doaj-08f4f138bc094a688e4cf85ab8ba3e0c2021-04-18T11:27:44ZengBMCJournal of Biological Engineering1754-16112021-04-0115113410.1186/s13036-021-00264-7Lymphocyte expansion in bioreactors: upgrading adoptive cell therapyOscar Fabian Garcia-Aponte0Christoph Herwig1Bence Kozma2Research Area Biochemical Engineering, Institute of Chemical, Environmental and Bioscience Engineering, TU WienResearch Area Biochemical Engineering, Institute of Chemical, Environmental and Bioscience Engineering, TU WienResearch Area Biochemical Engineering, Institute of Chemical, Environmental and Bioscience Engineering, TU WienAbstract Bioreactors are essential tools for the development of efficient and high-quality cell therapy products. However, their application is far from full potential, holding several challenges when reconciling the complex biology of the cells to be expanded with the need for a manufacturing process that is able to control cell growth and functionality towards therapy affordability and opportunity. In this review, we discuss and compare current bioreactor technologies by performing a systematic analysis of the published data on automated lymphocyte expansion for adoptive cell therapy. We propose a set of requirements for bioreactor design and identify trends on the applicability of these technologies, highlighting the specific challenges and major advancements for each one of the current approaches of expansion along with the opportunities that lie in process intensification. We conclude on the necessity to develop targeted solutions specially tailored for the specific stimulation, supplementation and micro-environmental needs of lymphocytes’ cultures, and the benefit of applying knowledge-based tools for process control and predictability.https://doi.org/10.1186/s13036-021-00264-7Adoptive cell therapyATMPBioreactorExpansionLymphocyteRocking motion |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Oscar Fabian Garcia-Aponte Christoph Herwig Bence Kozma |
spellingShingle |
Oscar Fabian Garcia-Aponte Christoph Herwig Bence Kozma Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy Journal of Biological Engineering Adoptive cell therapy ATMP Bioreactor Expansion Lymphocyte Rocking motion |
author_facet |
Oscar Fabian Garcia-Aponte Christoph Herwig Bence Kozma |
author_sort |
Oscar Fabian Garcia-Aponte |
title |
Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy |
title_short |
Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy |
title_full |
Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy |
title_fullStr |
Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy |
title_full_unstemmed |
Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy |
title_sort |
lymphocyte expansion in bioreactors: upgrading adoptive cell therapy |
publisher |
BMC |
series |
Journal of Biological Engineering |
issn |
1754-1611 |
publishDate |
2021-04-01 |
description |
Abstract Bioreactors are essential tools for the development of efficient and high-quality cell therapy products. However, their application is far from full potential, holding several challenges when reconciling the complex biology of the cells to be expanded with the need for a manufacturing process that is able to control cell growth and functionality towards therapy affordability and opportunity. In this review, we discuss and compare current bioreactor technologies by performing a systematic analysis of the published data on automated lymphocyte expansion for adoptive cell therapy. We propose a set of requirements for bioreactor design and identify trends on the applicability of these technologies, highlighting the specific challenges and major advancements for each one of the current approaches of expansion along with the opportunities that lie in process intensification. We conclude on the necessity to develop targeted solutions specially tailored for the specific stimulation, supplementation and micro-environmental needs of lymphocytes’ cultures, and the benefit of applying knowledge-based tools for process control and predictability. |
topic |
Adoptive cell therapy ATMP Bioreactor Expansion Lymphocyte Rocking motion |
url |
https://doi.org/10.1186/s13036-021-00264-7 |
work_keys_str_mv |
AT oscarfabiangarciaaponte lymphocyteexpansioninbioreactorsupgradingadoptivecelltherapy AT christophherwig lymphocyteexpansioninbioreactorsupgradingadoptivecelltherapy AT bencekozma lymphocyteexpansioninbioreactorsupgradingadoptivecelltherapy |
_version_ |
1721522230529097728 |